The Metropolitan Manila Development Authority (MMDA) has signed an agreement with the Philippine Health Insurance Corp. (PhilHealth) to provide health care insurance coverage for MMDA employees.
The accord was in line with Philhealth’s Konsultasyong Sulit Tama (Konsulta) program, a comprehensive outpatient benefits mandated by the Universal Health Care Law.
The document was signed by MMDA chairman Romando Artes, MMDA general manager Procopio Lipana, and PhilHealth – National Capital Region vice president Dr. Bernadette Lico in a ceremony held at the new MMDA head office in Pasig City.
Under the agreement, the MMDA will monitor the implementation of the Konsulta Program availed by its personnel and ensure the accreditation of the MMDA Medical Clinic.
The MMDA Medical Clinic shall perform preventive health services such as health screening and assessment according to the life stage and health risks of individuals.
The PhilHealth, on the other hand, shall facilitate the accreditation of the MMDA Medical Clinic following the accreditation standards, rules, and procedures as stipulated in the PhilHealth Circular for Konsulta Provider Accreditation.
Artes expressed his gratitude to PhilHealth-NCR for providing a package aimed to boost access to primary care services.
For her part, Dr. Lico thanked the MMDA for a fruitful collaboration with PhilHealth-NCR.
“I would like to personally convey my utmost gratitude to the dynamic chairman of MMDA and its officers for collaborating with us. Atty.
Artes welcomed us with open arms and showed his overwhelming support in boosting the KonSulta Program,” Lico said.
The Konsulta package covers preventive care including consultations, health risks screening and assessment, 13 laboratory tests, and 21 maintenance drugs and medicines.
Laboratory tests include complete blood count (CBC) with platelet count, urinalysis, fecalysis, sputum microscopy, fecal occult blood, pap smear, lipid profile, fasting blood sugar, oral glucose tolerance test, electrocardiogram (ECG), chest x-ray, creatinine, and hemoglobin A1c (HbA1c) test.